For many couples who endure repeated miscarriages, the search for a cause comes up empty: The embryos or fetuses have the normal number and assortment of chromosomes, and any routine ultrasounds prior to loss reveal no structural abnormalities. The lack of answers can be devastating for couples trying to build their families.
Now, Stanford Medicine researchers and their collaborators have identified possible genetic explanations in 30 of 118 such families. Previous studies of recurrent, chromosomally normal miscarriages had together analyzed only about 60 samples of miscarried pregnancies, often from just four to eight families at a time.
The team sequenced the genomes of the parents and the miscarried pregnancies in each family; earlier studies often sequenced only the miscarried pregnancies, making it hard to tell inherited genetic changes from those that arose in the embryo, or to distinguish harmful changes from harmless ones. In 18 families (15.3%), the researchers found variations, or changes, in genes involved in early human development that were likely to affect the gene's function (known as pathogenic, or likely pathogenic, variants). In 12 others (10.2%), they found variants of uncertain significance, meaning the evidence, although suggestive, isn't an established cause of miscarriage.
Most findings were inherited: In 24 of the 30 families, at least one parent carried the variant, usually while experiencing no symptoms themselves. Because a carrier parent can pass the same variant to more than one pregnancy, the findings may help explain why the losses recurred. The results also hint at ways couples with known genetic risk factors who have experienced recurrent pregnancy loss might one day lower their risk, such as testing embryos created through in vitro fertilization, or IVF, for a known pathogenic variant before transfer.
The findings offer these families something they have rarely had: a place to start.
"Some of these families have had 10 or more miscarriages, and some of them have no living children, without any explanation," said Svetlana Yatsenko , MD, professor of pathology at Stanford Medicine. "They have been told over and over again: 'It's bad luck. Try again.' We were not satisfied with the lack of explanation. This study is an opportunity for us to begin to understand why and to act on that."
Yatsenko shares senior authorship of the research , which was published Nov. 16 in Genome Medicine, with Ruth Lathi , MD, professor of obstetrics and gynecology at Stanford Medicine, and Aleksandar Rajkovic, MD, PhD, professor of pathology and of obstetrics, gynecology and reproductive sciences at the University of California, San Francisco. Mona Aminbeidokhti, PhD, a postdoctoral fellow at UCSF, is the lead author.
Repeated loss
Recurrent pregnancy loss, defined as two or more miscarriages, affects about 5% of couples. Roughly 70% of cases are chromosomally normal.
"Recurrent pregnancy loss is more than a medical diagnosis," said Lathi, who is the medical director of the Recurrent Pregnancy Loss program at Stanford Medicine. "Each loss can carry profound grief and lasting impact on pregnant people and families. Recurrent pregnancy loss is poorly understood and often goes unexplained. Finding answers for patients gets us one step closer to reducing pregnancy loss and helping our patients become parents."
Certain genes, when they're damaged, are known to cause lethal conditions in newborns. The researchers suspected that those damaged genes might also end pregnancies much earlier. Testing that idea is hard: A first-trimester loss typically leaves no visible birth defect, or phenotype, to point toward a particular genetic cause.
"There is no phenotype that can be linked to the genetic condition," Yatsenko said. "That's one of the biggest barriers to diagnosis."
The team, working at five academic centers, enrolled 176 families between 2022 and 2024. After excluding samples with chromosome abnormalities or poor-quality DNA that could not be analyzed, 118 families remained. About 79% of the losses occurred in the first trimester, and 95% of pregnancies showed no structural abnormalities on prenatal ultrasound.
Because sequencing turns up a few hundred potentially relevant variants in each family, the researchers prioritized genes that are tied to lethal conditions in stillborn babies and newborns, or that are linked to prenatal death in mice. Next, they checked published data on whether each gene is active in the developing embryo and fetus around the time the pregnancy loss occurred.
The most common pattern, seen in 11 families, was damage to both copies of one gene. Most people carry a working backup copy, so a parent with one damaged copy is usually healthy; trouble arrives when an embryo inherits a damaged copy from each parent.
In one family, both parents carried a damaged copy of DHCR7, a gene that helps regulate cholesterol. Babies born with two damaged copies have Smith-Lemli-Opitz syndrome, yet the disorder is rarer at birth than carrier rates predict, a gap widely thought to reflect early pregnancy losses. This family's 12-week loss added support for that idea.
Hints about miscarriage
Other patterns emerged. In five families, a variation in a gene located on the X chromosome was inherited by a male embryo, which has only one X chromosome and so has no backup healthy copy. In two families, a parent carried a variant in only some of their cells, including eggs or sperm, a condition called mosaicism.
In several families, a single damaged copy inherited from one parent appeared to be enough to end a pregnancy, even though that parent was healthy or only mildly affected. The embryo may simply be more vulnerable. Other inherited genes, stresses on the embryo or problems with the placenta may also tip the balance toward loss, the researchers suggest.
Not every miscarriage in a family carried the variant. In three families, two with variants in FGFR2, a gene that guides embryonic growth and patterning, and one with a variant in MAGED2, which helps regulate fetal fluid balances, there were samples from additional miscarriages that did not carry the variant, suggesting those losses may have had other causes.
In all, they identified variants in 28 genes. Thirteen had previously been linked to fetal or newborn death; 15 had never been reported in pregnancy loss. In four more families (3.4%), both copies of seven genes with no known link to human disease were damaged, but evidence was too limited to call them more than uncertain. Gene activity also fit the timing: HNRNPK, a gene that helps process genetic messages and is active broadly in the early embryo, was damaged in an eight-week miscarriage, while PRF1, part of the immune system's cell-killing machinery that is active later in development, was damaged in a 28-week loss.
For recurrent pregnancy loss, the results suggest that sequencing parents and miscarried pregnancies could one day supplement standard chromosome tests. A confirmed pathogenic variant could also help doctors counsel couples about their chances of another loss. However, the researchers caution that variants of uncertain significance and newly proposed genes should not guide embryo selection or other medical decisions until more evidence accumulates.
The team is enrolling additional families to confirm that the genes identified in this study truly cause pregnancy loss.
The findings suggest that testing prospective parents, much as couples are screened before pregnancy for variants that cause severe childhood disease, may be appropriate in some cases. "It's the same concept we have for preconception carrier screening, only that concept applies to the birth of severely affected children," Yatsenko said. "This would be a concept for the risk of miscarriage. Maybe there are prevention steps that can be implemented before you get pregnant."
Researchers from UCSF, Oregon Health & Science University, the University of Illinois Chicago, and Natera contributed to the work.
The study was funded by the National Institutes of Health (grant R01 HD105256).